TRAP-1 may prevent cancer cell death, current research suggests
March 19th, 2010
Current research suggests that TNF-receptor associated protein-1 (TRAP-1) may prevent cancer cell death. The related report by Leav et al, "Cytoprotective Mitochondrial Chaperone TRAP-1 as a Novel Molecular Target in Localized and Metastatic Prostate Cancer," appears in the January 2010
Noisy Workplaces Significantly Raise Risk Of Serious Heart Disease
March 18th, 2010
People who work in places where they are exposed to persistently high levels of noise have double the risk of developing serious heart disease compared to employees in other places, say researchers in an article in the peer-reviewed journal Occupational and Environmental Medicine. If the employee is young, male and a smoker the risk is […]
No Link Found Between Decrease In Suicide And Newer Antidepressants
March 14th, 2010
Many researchers have studied the relationship between the increase in sales of new antidepressants in recent decades and a simultaneous decline in the suicide rate. In a study based on figures from the Nordic countries, researchers at the Norwegian Institute of Public Health found no evidence that increased sales of the new medicines could be […]
Testosterone To Treat ‘Male Menopause’ Questionable
March 13th, 2010
Given that it is not clear whether male menopause actually exists, and inconclusive evidence on testosterone’s effectiveness in treating it, an article in today’s Drug Therapeutics Bulletin (DTB), a BMJ (British Medical Journal) journal, says that the use of synthetic testosterone is questionable.
Testosterone levels drop by approximately 1% to 2% annually from the age of […]
Scientific Data Relating To Cinryze(TM) (C1 Esterase Inhibitor [Human]) Presented At International Congress Of The Southern European Allergy Society
March 12th, 2010
ViroPharma Incorporated (Nasdaq: VPHM) announced the presentation of two abstracts relating to Cinryze™ (C1 esterase inhibitor [human]) therapy at the First International Congress of the Southern European Allergy Society in Florence, Italy.
Cinryze was approved by the U.S. Food and Drug Administration in October 2008 for routine prophylaxis against hereditary angioedema (HAE) attacks in adults and […]